A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)-Reference-Cited by-同舟云学术

A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)

Published:2021-11-18 Issue: Volume: Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Kufner Sebastian¹^ORCID,Rai Himanshu¹²³^ORCID,Wiebe Jens¹^ORCID,Altevogt Felix¹,Pyxaras Stylianos⁴^ORCID,Joner Michael¹⁵,Xhepa Erion¹^ORCID,Cassese Salvatore¹^ORCID,Colleran Roisin¹²³,Schunkert Heribert¹⁵,Zrenner Bernhard⁴,Kastrati Adnan¹⁵,Byrne Robert A.¹²³^ORCID,

Affiliation:

1. Klinik für Herz‐ und Kreislauferkrankungen Deutsches Herzzentrum München, Technische Universität München Munich Germany

2. Cardiovascular Research Institute Dublin Mater Private Network Dublin

3. School of Pharmacy and Biomolecular Sciences RCSI University of Medicine and Health Sciences Dublin

4. Medizinische Klinik I Krankenhaus Landshut‐Achdorf Landshut Germany

5. DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance Munich Germany

Funder

Boston Scientific Japan

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30014

Reference26 articles.

1. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis

2. Drug-coated balloon therapy in coronary and peripheral artery disease

3. Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

4. Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)

5. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent Restenosis;JACC: Cardiovascular Interventions;2024-01

2. One-year safety and effectiveness of the Agent paclitaxel-coated balloon for the treatment of small vessel disease and in-stent restenosis;Cardiovascular Intervention and Therapeutics;2023-08-29